2017
DOI: 10.1167/tvst.6.2.5
|View full text |Cite
|
Sign up to set email alerts
|

Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources

Abstract: This report emerges from a workshop convened by the National Eye Institute (NEI) as part of the “Audacious Goals Initiative” (AGI). The workshop addressed the replacement of retinal ganglion cells (RGCs) from exogenous and endogenous sources, and sought to identify the gaps in our knowledge and barriers to progress in devising cellular replacement therapies for diseases where RGCs die. Here, we briefly review relevant literature regarding common diseases associated with RGC death, the genesis of RGCs in vivo, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 103 publications
0
13
0
Order By: Relevance
“…Our data add details to the intrinsic immune response in the retina that is required for stem cell-based regeneration of photoreceptors. It is interesting to note that in the transcriptomes of Müller glia in both zebrafish and mouse models of photoreceptor degeneration the activation of cytokine pathways is conserved (Roesch et al, 2012;Sifuentes et al, 2016), suggesting that modulating intrinsic cellular mechanisms may be a promising therapeutic avenue to regenerate retinal neurons (Vetter et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Our data add details to the intrinsic immune response in the retina that is required for stem cell-based regeneration of photoreceptors. It is interesting to note that in the transcriptomes of Müller glia in both zebrafish and mouse models of photoreceptor degeneration the activation of cytokine pathways is conserved (Roesch et al, 2012;Sifuentes et al, 2016), suggesting that modulating intrinsic cellular mechanisms may be a promising therapeutic avenue to regenerate retinal neurons (Vetter et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…The design of new strategies to increase the proliferative and neurogenic potential of mammalian Müller glia is one of the areas of interest in the development of regenerative therapies for retinal degenerative diseases (Vetter and Hitchcock, 2017;Yao et al, 2018). Attempts to apply in vivo the transcription factor Ascl1, either alone or in combination with other factors such as miRNA or drugs that impact chromatin organization, interfered with the neurogenic potential of Müller glia.…”
Section: Discussionmentioning
confidence: 99%
“…Concern has also been raised about direct transfer of proteins between donor and host cells that could have misled the identification of donor cell integration, although no material transfer has yet been detected in RGCs (Boudreau-Pinsonneault and Cayouette, 2018;Nickerson et al, 2018;Pearson et al, 2016;Santos-Ferreira et al, 2016;Singh et al, 2016). An alternative approach is to promote de novo genesis of RGCs in adult retina via in vivo reprogramming (Vetter and Hitchcock, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…The design of new strategies to increase the proliferative and neurogenic potential of mammalian Muller glia is one of the areas of interest to develop regenerative therapies for retinal degenerative diseases (Vetter et al, 2017). Attempts to apply the transcription factor Ascl1, either alone or in combination with other factors such as miRNA or drugs that impact the chromatin organization, interfered with the neurogenic potential of Müller glia, but did not lead to the generation of ganglion cells (Pollak et al, 2013; Ueki et al, 2015; Jorstad et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Though promising, low integration efficiency, as well as rejection by the host pose significant challenges to cell therapy. An alternative approach is to promote de novo genesis of RGCs in adult retina via in vivo reprogramming (Vetter et al, 2017).…”
Section: Introductionmentioning
confidence: 99%